| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 751 | 2019 |
| Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy S Da Mesquita, Z Papadopoulos, T Dykstra, L Brase, FG Farias, M Wall, ... Nature 593 (7858), 255-260, 2021 | 218 | 2021 |
| Trial of prasinezumab in early-stage Parkinson’s disease G Pagano, KI Taylor, J Anzures-Cabrera, M Marchesi, T Simuni, K Marek, ... New England Journal of Medicine 387 (5), 421-432, 2022 | 179 | 2022 |
| Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid A Drieu, S Du, SE Storck, J Rustenhoven, Z Papadopoulos, T Dykstra, ... Nature 611 (7936), 585-593, 2022 | 104 | 2022 |
| Neurological manifestations of autosomal dominant familial Alzheimer’s disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network … M Tang, DC Ryman, E McDade, MS Jasielec, VD Buckles, NJ Cairns, ... The Lancet Neurology 15 (13), 1317-1325, 2016 | 104 | 2016 |
| Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study E Morenas-Rodríguez, Y Li, B Nuscher, N Franzmeier, C Xiong, ... The Lancet Neurology 21 (4), 329-341, 2022 | 89 | 2022 |
| Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease S Müller, O Preische, HR Sohrabi, S Gräber, M Jucker, JM Ringman, ... Alzheimer's & dementia 14 (11), 1427-1437, 2018 | 82 | 2018 |
| Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease BM Brown, HR Sohrabi, K Taddei, SL Gardener, SR Rainey‐Smith, ... Alzheimer's & dementia 13 (11), 1197-1206, 2017 | 65 | 2017 |
| Metabolic correlates of dopaminergic loss in dementia with Lewy bodies M Huber, L Beyer, C Prix, S Schönecker, C Palleis, BS Rauchmann, ... Movement Disorders 35 (4), 595-605, 2020 | 56 | 2020 |
| Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure J Vöglein, J Tüttenberg, M Weimer, L Gerigk, HU Kauczor, M Essig, ... Investigative radiology 46 (6), 390-400, 2011 | 56 | 2011 |
| Cortical [18F]PI‐2620 Binding Differentiates Corticobasal Syndrome Subtypes C Palleis, M Brendel, A Finze, E Weidinger, K Bötzel, A Danek, L Beyer, ... Movement disorders 36 (9), 2104-2115, 2021 | 53 | 2021 |
| A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data G Pagano, FG Boess, KI Taylor, B Ricci, B Mollenhauer, W Poewe, ... Frontiers in neurology 12, 705407, 2021 | 52 | 2021 |
| Seizures in Alzheimer’s disease are highly recurrent and associated with a poor disease course J Vöglein, I Ricard, S Noachtar, WA Kukull, M Dieterich, J Levin, A Danek Journal of neurology 267, 2941-2948, 2020 | 50 | 2020 |
| Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer’s disease J Vöglein, K Paumier, M Jucker, O Preische, E McDade, J Hassenstab, ... Brain 142 (5), 1429-1440, 2019 | 49 | 2019 |
| Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study J Luo, F Agboola, E Grant, CL Masters, MS Albert, SC Johnson, ... Neurology 95 (23), e3104-e3116, 2020 | 46 | 2020 |
| Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease SA Schultz, JF Strain, A Adedokun, Q Wang, O Preische, J Kuhle, S Flores, ... Neurobiology of disease 142, 104960, 2020 | 40 | 2020 |
| Dominantly Inherited Alzheimer Network. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nat. Med. 25 (2), 277-283, 2019 | 38 | 2019 |
| Seizures as an early symptom of autosomal dominant Alzheimer's disease J Vöglein, S Noachtar, E McDade, KA Quaid, S Salloway, B Ghetti, ... Neurobiology of aging 76, 18-23, 2019 | 34 | 2019 |
| Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease ECB Johnson, S Bian, RU Haque, EK Carter, CM Watson, BA Gordon, ... Nature medicine 29 (8), 1979-1988, 2023 | 32 | 2023 |
| Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy M Song, M Scheifele, H Barthel, T van Eimeren, L Beyer, K Marek, ... European journal of nuclear medicine and molecular imaging 48, 3872-3885, 2021 | 31 | 2021 |
